2009;102:428 36. 395. Lincoff AM, Bittl JA, Kleiman NS, et al. Comparison of bivalirudin ver- sus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial). Am J Cardiol. 2004;93:1092 6. 396. Lincoff AM, Bittl JA, Harrington RA, et al. Biva lirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned gly- coprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA. 2003;289:853 63. 397. Kastrati A, Neumann FJ, Mehilli J, et al. Bivalirudin versus unfraction- ated heparin during percutaneous coronary intervention. N Engl J Med. 2008;359:688 96. 398. Stone GW, Witzenbichler B, Guagliumi G, et al. Bivalirudin dur- ing primary PCI in acute myocardial infarction. N Engl J Med. 2008;358:2218 30. 399. Cohen M, Levine GN, Pieper KS, et al. Enoxaparin 0.3 mg/kg IV sup- plement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial. Catheter Cardiovasc Interv. 2010;75:928 35. 400. Collet JP, Montalescot G, Lison L, et al. Percutaneous coronary interven- tion after subcutaneous enoxaparin pretreatment in patients with unstable angina pectoris. Circulation. 2001;103:658 63. 401. Collet JP, Montalescot G, Golmard JL, et al. Subcutaneous enoxaparin with early invasive strategy in patients with acute coronary syndromes. Am Heart J. 2004;147:655 61. 402. Martin JL, Fry ET, Sanderink GJ, et al. Reliable anticoagulation with enoxaparin in patients undergoing percutaneous coronary intervention: the pharmacokinetics of enoxaparin in PCI (PEPCI) study. Catheter Cardiovasc Interv. 2004;61:163 70. 403. Levine GN, Ferrando T. Degree of anticoagulation after one subcutaneous and one subsequent intravenous booster dose of enoxaparin: implications for patients with acute coronary syndromes undergoing early percutane- ous coronary intervention. J Thromb Thrombolysis. 2004;17:167 71. 404. Steg PG, Mehta S, Jolly S, et al. 